MedPath

Gentamicin Intravesical Efficacy for Infection of Urinary Tract

Phase 2
Completed
Conditions
Pelvic Organ Prolapse
Postoperative Urinary Tract Infection
Stress Urinary Incontinence
Interventions
Other: Catheter clamping only
Registration Number
NCT04246996
Lead Sponsor
Kaiser Permanente
Brief Summary

Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gentamicin sulfate in 50 mL of saline versus usual care on the proportion of women treated for UTI within 6 weeks following surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
370
Inclusion Criteria
  • Adult women undergoing pelvic organ prolapse surgery and/or stress urinary incontinence surgery with surgical plan for at least 1 cystoscopy and will leave the operating room with a standard-of-care transurethral catheter.
  • Negative urine culture within 4 weeks or completion of UTI treatment ≥48 hours prior to surgery
Exclusion Criteria
  • History of allergic reaction or anaphylaxis to gentamicin sulfate or to sodium metabisulfite (one of the preservatives in the gentamicin sulfate product)
  • Abnormal intraoperative urinary tract finding (e.g. bladder mass, stone, or fistula)
  • Intraoperative urinary tract injury
  • Suppressive recurrent UTI treatment
  • Chronic indwelling catheter/self-catheterization
  • Unable to provide informed consent
  • Severe renal impairment - glomerular filtration rate of less than 30 mL / minute
  • Current pregnancy
  • Currently incarcerated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Gentamicin Armgentamicin sulfateAt the completion of the subjects surgery but prior to awakening from anesthesia, 80mg of gentamicin in 50 mL of normal saline will be infused into the subject's bladder through the standard-of-care transurethral catheter by the surgeon. The surgeon will then clamp the catheter and label the catheter with the clamping time. The catheter will be clamped to prevent the gentamicin from immediately flowing out of the bladder and thus allow the gentamicin time to have an effect. The subject will then proceed as usual to the postoperative anesthesia care unit. A member of the subject's care team will unclamp the catheter after 1 hour. The subject will otherwise have usual pre-operative and post-operative care.
Control ArmCatheter clamping onlyIf the patient is randomized to no instillation, at the end of the surgery but prior to awakening from anesthesia, the surgeon will clamp the catheter and label the catheter with the clamping time. The purpose of clamping the catheter for subjects receiving usual care will be to ensure patients are masked to study arm assignment if they wake up and notice their catheter. The subject will then proceed as usual to the postoperative anesthesia care unit. A member of the subject's care team will unclamp the catheter after 1 hour. The subject will otherwise have usual pre-operative and post-operative care.
Primary Outcome Measures
NameTimeMethod
Post-operative Urinary Tract InfectionWithin 6 weeks after surgery

Number of participants in each arm treated with antibiotics for urinary tract infection symptoms

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Isolated Uropathogen on Post-operative Urine CultureWithin 6 weeks after surgery
Adverse EventsWithin 6 weeks after surgery

Hospital readmissions

Trial Locations

Locations (2)

UC San Diego Health

🇺🇸

La Jolla, California, United States

Kaiser Permanente San Diego

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath